FIELD: medicine, cardiology.
SUBSTANCE: the present innovation deals with decreasing side effects of medicinal preparation of cardiotoxic component. For this purpose it is suggested to apply cariporide to decrease unfavorable impact of macrolide antibiotic, rulide, in particular. The innovation suggested provides the chance to remove side effects of macrolide antibiotic regarding patient's heart under conditions of ischemia and reperfusion.
EFFECT: higher efficiency of application.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
| USE OF TALIPORFIN OR ITS DERIVATIVES IN TREATMENT OF HEART DISEASES, AND ALSO THEIR DERIVATION | 2001 |
|
RU2350326C2 |
| PENTAFLUOROSULFANYLBENZOYLGUANIDINES, METHOD FOR THEIR PREPARING, THEIR USING AND MEDICINAL AGENT | 2003 |
|
RU2315752C2 |
| FLUORINATED CYCLOALKYL-SUBSTITUTED BENZOYLGUANIDINES, METHOD FOR THEIR PREPARING, THEIR USING AS MEDICINAL AGENT AND MEDICINAL AGENT COMPRISING THEREOF | 2003 |
|
RU2305093C2 |
| PENTAFLUOROSULPHANYL-BENZOYL GUANIDINES, SYNTHESIS METHOD THEREOF, USE THEREOF AS MEDICINAL OR DIAGNOSTIC AGENTS, AS WELL AS MEDICINAL AGENTS CONTAINING SAID COMPOUNDS | 2004 |
|
RU2380358C2 |
| AGENT FOR INCREASING RESISTANCE OF HEART TO ARRYTHMOGENIC ACTION OF ISCHAEMIA AND REPERFUSION | 2014 |
|
RU2587783C1 |
| AGENT POSSESSING ANTIARRHYTHMIC ACTION | 2019 |
|
RU2700263C1 |
| CARDIOPROTECTIVE AND ANTIARRHYTHMIC MEDICINE | 2022 |
|
RU2783444C1 |
| AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
| ANTIARRHYTHMIC DRUG | 2017 |
|
RU2664668C1 |
